Medicaid Managed Care Contracting for Childhood Lead Poisoning Prevention Services by Wehr, Elizabeth & Rosenbaum, Sara J.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Center for Health Policy Research Health Policy and Management
9-1998
Medicaid Managed Care Contracting for




Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/sphhs_policy_chpr
Part of the Health Law and Policy Commons, Health Policy Commons, and the Toxicology
Commons
This Report is brought to you for free and open access by the Health Policy and Management at Health Sciences Research Commons. It has been
accepted for inclusion in Center for Health Policy Research by an authorized administrator of Health Sciences Research Commons. For more
information, please contact hsrc@gwu.edu.
Recommended Citation
Wehr, Elizabeth and Rosenbaum, Sara J., "Medicaid Managed Care Contracting for Childhood Lead Poisoning Prevention Services"
(1998). Center for Health Policy Research. Paper 3.
http://hsrc.himmelfarb.gwu.edu/sphhs_policy_chpr/3
MEDICAID MANAGED CARE CONTRACTING 
FOR CHILDHOOD LEAD POISONING PREVENTION SERVICES 
ELIZABETH WEHR, J.D. 
RESEARCH SCIENTIST 
SARA ROSENBAUM, J.D. 
DIRECTOR AND 
PROFESSOR OF HEALTH SERVICES MANAGEMENT AND POLICY 
CENTER FOR HEALTH POLICY RESEARCH 
SCHOOL OF PUBLIC HEALTH AND HEALTH SERVICES 
THE GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER 
SEPTEMBER, 1998 
PREPARED WITH THE SUPPORT OF 
THE CENTERS FOR DISEASE CONTROL AND PREVENTION 
INTRODUCTION 
This study reports on provisions relating to childhood lead poisoning prevention 
services in Medicaid managed care contract documents (service agreements and requests for 
proposals, RFPS). The provisions were extracted from the managed care contracts data base of 
the Center for Health Policy Research of the George Washington University Medical Center. 
The data base was constructed and is updated as part of the Center's ongoing analytic studies.' 
As with other Center studies of the contract documents, this is a descriptive study of how state 
Medicaid agencies addressed a series of contracting issues at a specific point in time.* 
In brief, we found that a substantial number of the 42 contract documents in the data base 
addressed screening enrolled children for elevated blood lead levels (EBLLS) as a duty of 
managed care organizations (MCOs) serving Medicaid beneficiaries. However, very few 
documents addressed either medical followup for children for whom screening showed EBLL or 
integration of medical followup with public health agency activities to identify and reduce lead 
hazards in the homes of enrollees with EBLL. This last finding is consistent with a major finding 
of our larger studies, that at the time the contract documents we analyzed were drafted, state 
Medicaid agencies were just beginning to consider interactions between MCOs enrolling 
Medicaid beneficiaries and other public agencies with health-related duties toward enrollees. 
We also found that the contract documents rarely identified lead-related services in either 
quality assurance or as a specific MCO reporting duty. Thus, while managed care is viewed as a 
means of providing medical homes for Medicaid children and creating administrative systems for 
tracking and assuring provision of care, the contract documents suggest that many states have yet 
to really grasp the potential of managed care to provide a tool for improving the quality of lead- 
related treatment services. 
After setting out our methods, findings and discussion of findings, we provide the 
contract language excerpts on which the analysis is based. 
1 S. Rostnbaum ct IL, Ntgortoring the New Health System: A Nationwide Study of Medicaid Managed Care 
Contracts, Center f a  Health Poky Research, The George Washington University Medical Center (First Edition, 
1997: Second Edition. 1998). 
~, 
2. This report was completed August 3 1, 1998 and has been updated to include current Health Care Financing 
Administration policy on lead poisoning, as set out in revisions to the HCFA State Medicaid Manual. 
Center for Health Policy Research 
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A. METHODS 
Negotiating the New Health System is a descriptive, point in time study of Medicaid 
managed care contracts, prepared from the Center's unique contracts data base. The data base 
consists of provisions extracted from 42 comprehensive medical services contracts (service 
agreements or requests for proposals (RFPs)) for Medicaid managed care services, in effect as of 
the beginning of 1997.' A group of attorneys and health services researchers constructed the 
data base by a) developing a review instrument reflecting all major domains that are typically 
addressed in such contract documents; b) reading the contract documents against the instrument 
to identify contract language addressing the questions in the review instrument; c) entering the 
language into the data base; and d) sorting the excerpts by domains, topics within domains, and 
by states. State Medicaid agencies were asked to review the resulting data in draft form to make 
any necessary corrections or additions4 
The review instrument for the project, which was reviewed by a multi-disciplinary 
advisory group is designed to determine whether a contract document identifies a particular topic 
and if so, how it addresses the topic. The study allows for a direct comparison of state 
approaches to all aspects of Medicaid-serving managed care systems. The function of the data 
base is to permit analysts to (a) identify the topics that states elect to address specifically and (b) 
understand the manner in which states address them. 
For this study, we extracted all provisions from the data base that included the word 
"lead" and sorted the provisions into four domains: These domains are: Benefits and Service 
Duties; Quality Assurance and Performance Measures; Data Collection and Reporting (which 
includes submission of samples for blood lead testing to state public health laboratories); and 
Relationships with Public Health Agencies. The four domains reflect the nature of the contract 
provisions addressing childhood lead poisoning prevention services that we found. For example, 
while the overall study includes a domain dedicated to provider network competency and 
capabilities, we did not find language specifically addressing this domain. Thus, there are no 
extractions to report in this area. 
Lead screening is a required element of the Medicaid Early and Periodic Screening, 
Diaenostic and Treatment Services (EPSDTi' benefit for children. Certain states elected to - ~ w - - - -  ~~ 
incorporate state or federal EPSDT laws, regulations, Medicaid provider manuals or other 
guidance into their Medicaid managed care contracts, without specifically identifying the 
3 The data base contains an additional 12 "carve-out" contract documents related to mental health or behavioral 
health services. 
4 The data base identifies regulations, statutes, Medicaid provider manuals and other materials incorporated by 
reference into the contracts but does not present them. 
5 42 U.S.C. $1396(r). 
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individual elements of this benefit, including lead screening. Because our search was limned to 
provisions that included the word "lead, we do not report on this drafting strategy . Thus, to 
some extent the study may understate the number of Medicaid managed care contract documents 
that actually require an MCO to famish lead-related services for enrolled beneficiaries. Under 
contract law, materials incorporated into an agreement are legally enforceable, but unless a 
Medicaid contract cleqly requires the MCO to meet all applicable standards under federal law, a 
general reference to EPSDT may be sufficiently ambiguous that no or limited lead-related duties 
are created. ' 
This caveat about findings on benefits and service duties does not apply to the domains of 
quality assurance, reporting and relationships between MCOs and public health agencies. Since 
these domains do not rest on external federal legal requirements, there is no broader, 
compensatory legal duty that substitutes for the omission of an express lead-related duty:' 
Certain provisions fall into more than one domain. For example, a quality assurance 
provision may also contain reporting requirements. In the excerpts section, we show such 
language in both domains. 
B. FINDINGS AND ANALYSIS 
Benefits and Service Duties: Twenty of the 42 contract documents in the data base 
contain language addressing MCO duties relating to lead-related care. Generally, this language 
was limited to screening. Fifteen of the 20 contracts specifically required screening enrolled 
children by means of blood lead laboratory tests or "blood lead levels," which we read to mean 
laboratory tests. One contract, Tennessee, required prenatal lead screening. 
Certain states required the screenings in accordance with the "EPSDT periodicity 
schedule." A few set out the children's ages or frequency with which screening services were to 
6 Ambiguities in an contract would generally be construed against the Medicaid agency as the drafter of the contract 
with the result that the agency may remain financially liable for lead-related services that it intended the Contractor 
to cover. Ambiguitia could arise from the drafting of the EPSDT contract language; from general rules of 
construction included in the contract: from the contractor's discretionary authority under the contract to determine 
the "medical necessity" of covered services; or other factors. 
7 State public health statute! and regulation! that Beat diagnosis of elevated blood lead levels as a notifiable event 
typically create reporting duties for health care professionals and laboratories but not MCOs. However, a managed 
care contract can create a duty for the MCO to assure adherence to such reporting duties by its paRicipaIing 
providers and laboratories. 
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be furnished.' Five of the 20 simply specified lead levels (or screening) for enrollees under age 
21; three (Massachusetts, Missouri, and Utah) required such services at age 6 months through 72 
months: one (New Hampshire) also required screening for children younger than 6 months "when 
medically necessary." One contract (Massachusetts) contained detailed requirements for verbal 
risk assessments and the use of such assessments in determining frequency of tests (and other 
services). 
. . A  child's level of risk for exposure to lead depends upon the answers to the above questions 
- 
'The data on which our study was based predates the 1998 Health Care Financing Administration (HCFA) 
clarification of federal Medicaid policy on lead-related services, which is set out below. 
Lead Toxicity Screening. - all children are considered at risk and must be screened for 
lead poisoning. HCFA requires that all children receive a screening blood lead test at 12 months 
and 24 months of age. Children between the ages of 36 months and 72 months of age must 
receive a screening blood lead test if they have not been previously screened for lead poisoning. 
A blood lead test must be used when screening Medicaid-eligible children. A blood lead test 
result equal to or greater than 10 ug/dL obtained by capillary specimen (fingerstick) must be 
confirmed using a venous blood sample. 
At this time, states may not adopt a statewide plan for screening children for lead poisoning that 
does not require lead screening for all Medicaid-eliglble children. 
a. Diagnosis, Treatment, and Follow-Up. -- If a child is found to have blood lead levels 
equal to or greater than 10 ug/dL, providers are to use their professional judgment, with reference 
to CDC guidelines covering patient management and treatment, including follow up blood tests 
and initiating investigations to determine the source of lead, where indicated. Determining the 
source of lead may be reimbursable by Medicaid under certain circumstances. Reimbursement is 
limited to a health professional's time and activities during an on-site investigation of a chilod's 
home (or primary residence). The child must be diagnosed as having an elevated blood lead level, 
Medicaid reimbursement is not available for any testing of substances (water, paint, etc.) which 
are sent to a laboratory for analysis. 
b. Coordination With Other Agencies. - Coordination with WIC, Head Start, and other 
private and public resources enables elimination of duplicate testing and ensures comprehensive 
diagnosis and treatment. Also, public health agencies' childhood lead poisoning prevention 
programs may be available. These agencies may have the authority and ability to investigate a 
lead-poisoned child's environment and to require remediation. HCFS, Slate Medicaid Manual 
55 132.20 (revised effective April 16, 1998). 
In a letter notifying State Medicaid Directors of this clarification, HCFA also indicated that the screening schedule 
set out above is aminimum standard and that children may receive additional screening tests at other times:. 
Any additional blood lead tests continue to be covered based on a provider's medical judgment, as 
well as any medically necessary diagnostic and treatment services coverable under Medicaid. 
Letter of April 13, 1998 from Sally K. Richardson, Director of the Health Care Financing 
Administration Center for Medicaid and State Operations to state Medicaid directors. 
Center for Health Policy Research 
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[which are set out in the contract]. If the answers to all questions are negative, a child is 
considered at low risk for high doses of lead exposure. If the answers to any question is 
affirmative, a child is considered at high risk for high doses of lead exposure. A child's risk 
category cm change with each administration of the verbal risk assessment .... The frequency with 
which the blood lead test is to be administered depends upon the results of the verbal risk 
assessment. ..' 
Very few contracts addressed the duty to provide or arrange for the integrated regimen of 
medical and environmental services without which children's elevated blood lead levels cannot 
effectively be reduced. Indeed, few even specified the followup diagnostic and treatment 
services for children with EBLL, which would be appropriate in a medical services contract. 
None addressed the evidence that would be considered sufficient to establish the medical need 
for such services, for purposes of coverage determinations, or treatment protocols to be followed. 
The Massachusetts and Utah contracts offer exceptions to this overall practice. 
The fact that the contracts do not specifically address followup medical services does not. 
of course, mean that they would not be furnished a s  covered pharmacy, laboratory and 
other general categories of services. Contract silence, however, confers discretion on the MCO 
and i t s  providers to determine what will be done following discovery of an EBLL in an enrolled 
child. 
The coordination of medical services (ongoing testing to monitor a child's lead level and 
necessary treatment) with reduction of lead hazards in the home of a child with EBLL 
historically has been arranged by state, regional or local health agencies (and childhood lead 
poisoningprevention programs &thin tho& agencies) , through &ulti-diisciplinary case 
management (also known as care coordination) and liaison with environmental and housing 
agencies. only one contract, Missouri, addressed multi-disciplinary case management for a child 
with EBLL, although it does not mention environmental services specifically: 
...HCY [the state's EPSDT program] Case Management can be used to reach out beyond the 
bounds of the Medicaid program or health plan to coordinate access to a broad range of services, 
regardless of the source of funding for the services. The services to which access is gained 
must be found by the health plan to be medically necessary for the child. HCY 
Case Management services are @tended to assist individuals in gaining access to needed medical. 
social, educational and other services. The health plan may assist the individual in accessing these 
services. 
Lead Caw Management: Plans must screen children for elevated blood lead levels as part of the 
requirement for the EPSDTMCY program. When a child is identified with an elevated blood lead 
level, the health plan is responsible for providing medically necessary services including case 
management for the child. ..' 
Quality Assurance and Performance Measures: Eleven of the 42 contracts contain 
language establishing some type of quality or performance standards relating specifically to lead. 
Center for Health Policy Research 
The George Washington University Medical Centget. 
Five contract documents (Florida, Kansas, New Jersey, Rhode Island, Texas) identified lead or 
"lead toxicity" as an optional or mandatory area for an MCO's quality-related activities. TWO 
... . - 
states (New Jersey and Wisconsin) established performance standards for lead screening. For 
example, the Wisconsin contract establishes the following "objective": 
"..Theobjective fcr calendar year 1997 is 50% of all Medicaid enrollees with their first or second 
birthday during the reporting period (calendar year 1997) who are continuously enrolled for the 
I2 months prior to their first or second birthday will have had one blood lead test. Two rates must 
be reported, one for one year Olds and one for two year Olds ..." 
This measure would, of course, capture rates only of Medicaid enrollees with relatively 
stable program eligibility and enrollment in the reporting managed care plan. 
One state, Rhode Island, requires the MCO to establish an internal tracking system to 
monitor provision of EPSDT services including, specifically, "Preventive pediatric visits in 
accordance with" the state's EPSDT periodicity schedule and the state's health department "lead 
guidelines." 
Data Collection and Reporting. Ten of the 42 contact documents contain lead-specific 
reporting specifications. These provisions fall into two broad categories: reporting relating to 
provision of lead services and reporting relating to public health surveillance. Service-related 
reporting duties ranged from encounter data reporting (D.C.) to quality assurance data reporting 
(Texas) and utilization data (Wisconsin). Public health-related reporting including requirements 
to submit blood lead test samples to state health laboratories in three states (Illinois, Rhode 
Island and Vermont). Note that the following language from the Vermont contract also obligates 
the Contractor and its providers to ensure that any out-of-state laboratories with which they do 
business comply with the state's reporting requirements. As managed care organizations (and 
their providers) consolidate their laboratory work in organizations serving multiple states, such 
contract language appears to be the only means of assuring reporting to a state's lead surveillance 
programs. 
. .  Contractor shall submit all reference specimens for the confirmation of positive blood lead ... It 
is the responsibility of the Contractor to comply with Vermont disease reporting requirements ... 
The Contractor and/or their participating providers (as applicable) who contract with out-of-state 
labs, are responsible for ensuring that the lab vendor complies with Vermont's disease reporting 
requirements ...* 
Relationships with Public Health Agencies: Nine of the 42 contracts address some type of 
relationship (other than reporting) between the MCO and a public health agency with regard to 
lead services. A few contracts specifically address the relationship between contract services 
and public health agency programs (e.g., childhood lead poisoning prevention programs) 
regarding lead "assessment" or testing services (Missouri, Montana) or services to identify and 
or reduce lead hazards in the environment of a child enrollee with EBLL (New York, Vermont, 
Center for Health Policy Research 
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Wisconsin). Where the services furnished by a public health agency to a Contractor's enrollee 
are medical services the contractor is obligated to reimburse the agency (Montana) or the 
Medicaid agency pays the agency directly (Missouri). Where the services furnished by the health 
agency are public health or epidemiological interventions - i.e., environmental investigations or 
other "followup services", the services appear to remain the financial responsibility of the health 
agency. 
The contracts addressing provision of epidemiological services may or may not require 
the MCO to coordinate its medical services with environmental or other followun services 
furnished by the health agency. Under the New York contract: 
. .Health plan PCPs will be responsible for screening, diagnosing and treating children with 
elevated blood lead levels. PlansPCPs also must coordinate the care of such children with local 
health departments to assure appropriate follow-up by the departments in terms of environmental 
investigation and risk management." 
In contrast, the less specific Wisconsin language specifies that: 
T h e  following specific services have been delineated with the hope of linking Medicaid Managed 
Care Plans with Local Health Departments. Linking primary care and public health is an essential 
strategy to strengthen the health of local communities and thus benefit the population of the state 
as a whole ... 
LHDs provide health-related homdcommunity inspections in areas that include Lead Poisoning." 
Other types of MCO-public health agency relationships envisioned by the contacts 
include provision by the health departments of "recommended medical protocols" for lead 
screening (e.g., ~ e w  Hampshire) &d, as mentioned above, submission of samples for blood lead 
testing to state laboratories. 
C. DISCUSSION 
Under fee for service Medicaid, the promise of universal lead screening for Medicaid 
children has not been realized. The General Accounting Office (GAO) reported in February, 
1998 reported very low Medicaid lead screening rates in a national sample of children screened 
between 1991 and 1994, before most states had converted their Medicaid programs to managed 
care? 
'united Slates General Accounting Office, Medicaid: Elevated Blood Lead Levels in Children 
Center for Health Policy Research 
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We found that about half the contract documents examined for this study addressed lead- 
related services for children, primarily screening. Quality assurance standards for these services 
as well as lead-~pecific reporting duties are relatively rare, as are provisions addressing 
relationships between MCOs and agency providers of non-medical services relating to 
environmental lead. We conclude that at the time the contracts we studied were drafted, only a 
few states were beginning to realize the enormous potential of Medicaid managed care to 
improve Medicaid children's access 
We suggest that sample purchasing specifications, setting out a full range of drafting 
options for lead-related services, may assist state Medicaid agencies, public health agencies and 
managed care organizations in determining the appropriate roles and responsibilities of each 
entity in reducing elevated blood lead levels in enrolled children. 
(GAOMEHS-98-78, February, 1998) GAO estimated that one in twelve Medicaid children ages one through five, or 
about a half a million, had hannful effects of lead in their blood when screened for the National Health and 
Nutrition Examination survey (NHANES), For nearly two-thirds of these children, the NHANES screening was the 
first blood lead level test that they had received. While GAO did not explore the reasons so few Medicaid children 
receive lead screening, the most likely explanations are the difficulties many Medicaid families have had in finding 
physicians who will accept them into their practices, lack of information for families about the potential for lead 
poisoning for their children and, possibly, low priority among many physicians for lead screening. 
Center for Health Policy Research 
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Benefits and Service Duties 
D. LEAD-RELATED EXTRACTS FROM 
MEDICAID MANAGED CARE CONTRACT DOCUMENTS 
"XIII. SERVICE DELIVERY ... 
.The  following requirements related to the provision of 
EPSDT services and must be incorporated into the Contractor's 
preventive health services ... 
(I)  EPSDT Services ... 
The EPSDT examination or health screening consists of:... 
f. Laboratory Testing (including lead toxicity screening which 
must be done according to the state's EPSDT periodicity 
table) ..." Colorado Contract, pages 7A, 8A. 
"Article 7 
SERVICE DELIVERY AND QUALITY ASSURANCE 
REQUIREMENTS 
GENERAL ... 
H. Each Provider shall provide Early and Periodic Screening, 
Diagnosis, and Treatment (EPSDT) Services (well-child 
services) in accordance with the D.C. Medicaid State Plan. 
EPSDT services shall include, but are not limited to, the 
following: 
1. Notifying the parents of enrolled children under the age of 
21 that the children are entitled to an annual examination and 
evaluation of their general physical and mental health and 
growth, 
development and nutritional status, and provide, or arrange for, 
such examination for the eligible 
children. The children of those parents who request the 
examinations shall receive the examination within 30 days of 
the date of the request. At a minimum these examination must 
include a comprehensive health and developmental history; a 
comprehensive unclothed physical examination; vision testing; 
hearing testing; appropriate laboratory tests (including lead 
blood levels) ..." District of Columbia Contract, pages 7,8. 
"6.1.1.2 Screens 
MCOs must provide screenings (periodic comprehensive child 
health assessments) to all eligible 
EPSDT recipients who request them. These should be regularly 
scheduled examinations and 
evaluations of the general physical and mental health, growth, 
development, and nutritional status of infants, children, and 
youth. At a minimum, these screenings must include, but are 
not limited to: 
(g) Blood lead testing ..." Delaware RFP, pages 11.24,11.25. 
The George Washington University Medical Center 
Center for Health Policy Research 
'a. The health screening examination shall consist 
of. ..nutritional assessment ... laboratory testing 
(including lead screening); health education (including 
anticipatory guidance) ..." Florida Contract, page 84. 
"4.6 Continuing Care Provision (EPSDT) Provide all covered 
services to eligible Early and ~eriodic~creening, Diagnosis, 
and Treatment (EPSDT) recipients formally enrolled with the 
provider according to the periodicity schedule found in 
Addendum XI, including: (1) screening, diagnosis, treatment 
and referral for follow-up ... (1 1) provide lead screening 
services as specified in the EPSDT periodicity schedule ..." 
Iowa 1997 Contract, pages 14-1 5. 
. Please see the Physician's Service Provider's Manual for the 
periodicity schedule and additional information regarding 
screening examinations ..." Iowa 1997 Contract, Addendum I, 
pages 59,60. 
"Initial, periodic and neonatal EPSDT screenings must include 
each of the following components: 
a. Identifying eligible enrollees at risk for lead absorption and 
performing a test for blood lead level. (The blood lead test is 
the only acceptable laboratory screening test. The erythrocyte 
protoporphyrin test is not acceptable as a screening test for lead 
poisoning.); " Maine RFP, Appendix 6, pages 3-6. 
. . (  1 1) Lead Toxicity Screening. The required screen for the 
presence of lead toxicity in children consists of two 
components: verbal risk assessment and blood lead testing. 
(a) Verbal Risk Assessment. The provider must perform a 
verbal risk assessment for lead toxicity at every periodic visit 
between the ages of six and 72 months a s indicated on the 
Schedule. The verbal risk assessment includes,-at a minimum, 
the following types of questions: (I) Does your child live in or 
regularly visit a house built before I960? Does the house have 
peeling or chilling paint? 
(ii) Was your child's day care center/preschool/babysitter's 
home built before I960? Does the house have chipping or 
peeling paint? 
(iii) Does you child live in a house built before 1960 with 
recent, ongoing, or planned renovation or remodeling? 
(iv) Have any of your children or their playmates had lead 
poisoning? 
(v) Does your child frequently come in contact with an adult 
who works with lead? Examples include construction, welding, 
pottery, or other trades practiced in your community. 
(vi) Does your child live near a lead smelter, battery recycling 
plant, or other industry likely to release lead, such as (give 
examples in your community)? 
(vii) Do you give your child home or folk remedies that may 
contain lead? 
(viii) Does your child live near a heavily traveled major 
highway where soil and dust may be contaminated with lead? 
(ix) Does your home's plumbing have lead pipes or copper 
pipes with lead solder joint? 
The George Washington University Medical Center 
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A child's level of risk for exposure to lead depends upon the 
answers to the above questions. If the answers to all questions 
are negative, a child is considered at low risk for high doses of 
lead exposure. If the answers to any question is affirmative, a 
child isconsidered at high risk for high doses of lead exposure. 
A child's risk category can change with each administration of 
the verbal risk assessment ... 
(b) Blood Lead Testing. Screening blood lead testing may be 
performed by either a capillary sample (finger stick) or a 
venous sample. However, all elevated blood levels (equal to or 
grater than 10 micrograms or 1 deciliter) obtained through a 
capillary sample must be confirmed by a venous sample. The 
frequency with which the blood lead test is to be administered 
depends upon the results of the verbal risk assessment. For 
children determined to be at low risk for high doses of lead 
exposure, a screening blood lead test must be performed once 
between the ages of nine and 12 months, and annually 
thereafter until the age of 48 months. For children determined 
to be at high risk for high doses of lead exposure, a screening 
blood lead test must be performed at the time a child is 
determined to be a high risk beginning at six months of age ... 
(I) If the initial blood lead test result; are less than 10 
micrograms per deciliter, a screening blood lead test is required 
at every subsequent periodic visit through 72 months of age, 
unless the child has already received a blood lead test at the 
periodic visit within the last six months. 
(ii) If the child is found to have a blood lead level equal to or 
greater than 10 micrograms per deciliter, providers should use 
their professional judgement, in accordance with the CDC 
guidelines regarding patient management and treatment, as 
well as follow-up blood test and initiation of investigations, to 
determine the source of lead, where indicated. 
(iii) If a child between the ages of 24 months and 72 mouths 
has not received a screening blood lead test, the child must 
receive the blood lead test immediately, regardless of whether 
the child is determined to be a low or high risk according to the 
answers to the above-listed questio ns..." Massachusetts 
Contract, Appendix E, Section I, unnumbered pages. 
"The components of the program are the following ... 
As specified in federal regulations, the screening component 
involves a general health screening most commonly known as a 
periodic well-child exam. EPSDT screening guidelines are 
based on the American Academy of Pediatrics' 
recommendations for preventive pediatric health care and 
include at a minimum: 
lead toxicity screening age 1-5 with blood sample for lead level 
determination as indicated interpretive conference and 
appropriate counseling for parents or guardians." Michigan 
RFP, page 27. 
. Services Included ... All services must be provided 
consistent with the scope of services covered by the Michigan 
Medicaid Program on a fee-for-service basis, unless otherwise 
specified by the Department. I lealth plans must reference all 
The George Washington University Medical Center 
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applicable Medicaid provider manuals and publications for 
coverages and limitations ... Blood lead follow-up services for 
individuals under the age of 2 1 ." Michigan RFP, pages 2 1-22. 
'... If a child is found to have elevated blood lead levels in 
accordance with standards disseminated by DCH, a referral 
should be made to the local health department for follow-up 
services which may include an epidemiological investigation to 
determine the source of blood lead poisoning." Michigan RFP, 
pages 27-28. 
"6.10 Early Periodic Screening Diagnosis and Treatment 
Services (EPSDT) The Division requires that the Contractor 
cooperate to the maximum extent possible with efforts to 
improve the health status of Mississippi citizens. Toward that 
end, the Contractor shall provide the full range of EPSDT 
services as defined in. and in accordance with, the Division's 
policies and procedures for EPSDT and the provisions of this 
Contract. Such services shall include, without limitation, 
periodic health screenings ... 
in accordance with the Periodicity Schedule established for 
EPSDT services including ... all medically necessary services ... 
The following minimum elements are to be included in the 
Periodic Health Screening Assessment ... 
e. Blood lead levels must be tested pursuant to Appendix N of 
the EPSDT provider manual. " Mississippi HMO Contract, 
page 19. 
"6.2.1 The health plan must conduct periodic early and 
periodic, screening, diagnosis, and treatment screens on all 
members under age twenty-one (21) to identify health and 
developmental problems. These screens include the following 
components: ... 
(g) Blood lead testing (mandatory 6-72 months) ..." Micouri 
RFP, page 29. 
10.7.1 Plans are responsible for ensuring the following core 
services are available to their members and for reimbursing the 
Department of Health and local health departments as 
specified ... 
(e) Childhood lead poisoning prevention services including 
screening, diagnosis and treatment. Plan providers shall follow 
current CDC guidelines: Preventing Lead Poisoning in Young 
Children. The Director of the Department of Health shall 
provide the plan's medical director with copies of current 
protocols and guidelines upon contract award or at any time 
upon request. 
10.7.2 Other services offered by the Department of Health and 
local health departments and the method of reimbursement 
include: 
(a) Environmental lead assessments for plan children with 
elevated blood levels will be reimbursed directly by the state 
Medicaid agency ...." Missouri RFP, pages 34, 34A, 34B, 35 
"CASE MANAGEMENT-1ICY and LEAD CASE 
The George Washington University Medical Center 
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MANAGEMENT (HCY) 
HCY Case Management: Health plans are required to provide 
medically necessary case 
management services for persons under the age of 21. Healthy 
Children and Youth (HCY) Case 
Management is an activity under which responsibility for 
locating, coordinating and monitoring 
necessary and appropriate services for a person under age 2 1 
rests with a health plan or an 
organization or individual with which the health plan has 
contracted. HCY Case Management is the process of collecting 
information on the health needs of the child, making (and 
following up on) referrals as needed, maintaining a health 
history, and activating the examination/diagnosis/treatment 
'loop'. 
HCY Case Management can be used to reach out beyond the 
bounds of the Medicaid program or 
health plan to coordinate access to a broad range of services, 
regardless of the source of funding for the services. The 
services to which access is gained must be found by the health 
plan to be medically necessary for the child. HCY Case 
Management services are intended to assist individuals in 
gaining access to needed medical, social, educational and other 
services. The health plan may assist the individual in accessing 
these services. 
Lead Case Management: Plans must screen children for 
elevated blood lead levels as part of (he 
requirement for the EPSDTIHCY program. When a child is 
identified with an elevated blood lead level, the health plan is 
responsible for providing medically necessary services 
including case management for the child. For those children 
who are enrolled in the Managed Care program, the health plan 
will be responsible for provision of the lead case management 
services ... " Missouri RFP, Attachment 8, pages 129,130. 
'Give each ENROLLEE, including adolescents, the 
opportunity go to any public health clinic for immunizations 
and blood lead testing (but not well-child screens) without 
requiring a referral. The CONTRACTOR shall also make a 
reasonable effort to contract with all county public health 
clinics. At a minimum the contractor shall reimburse such 
public health clinics at the MEDICAID rate. The 
CONTRACTOR may require public health clinics to submit 
claims or reports in specified formats before reimbursing 
services." Montana Contract, pages 1-10. 
"10. Lead poisoning screening for children under the age of six 
(6) and when medically necessary following the recommended 
medical protocols by the Childhood Lead Poisoning Prevention 
Program, Division of Public Health Services: ..." New 
Hampshire RFP, Exhibit A.3, page 3. 
"ATTACHMENT 1 EPSDT Protocol ... The contractor must 
provide EPSDT equivalent services ... 
1. EPSDT Screening Services which include: 
The George Washington University Medical Center 
Center for Health Policy Research 
d. Appropriate laboratory tests: The following list of screening 
tests is not all inclusive; additional laboratory tests may be 
appropriate and medically indicated (e.g., for ova and parasites) 
and shall be obtained as necessary: ... 
blood lead assessment using blood lead level determinations as 
part of scheduled periodic health screenings appropriate to age 
and risk must be done for children between 6 months and 6 
years of age according to the following schedule: ... 
between 6 months and 12 months at 24 months of age 
annually to six (6) years of age ... 
All screening must be done through a blood lead level 
determination. The EP test is no longer acceptable as a 
screening test for lead poisoning;" New Jersey Contract, 
pages 135-136. 
"NOTE: HCFA considers all Medicaid recipients between 6 
months and 6 years of age to be at risk for elevated blood lead 
levels. 
All screening must be done through a blood lead level 
determination. The EP test is no longer acceptable as a 
screening test for lead poisoning; however, it is still valid as a 
screening test for iron deficiency anemia ...." New Jersey 
Contract, Appendix A, page 130. 
"2.8.9.5 Lead Poisoning Health plan PCPs will be responsible 
for screening, diagnosing and treating children with elevated 
blood lead levels. PlansfPCPs also must coordinate the care of 
such children with local health departments to assure 
appropriate follow-up by the departments in terms of 
environmental investigation and risk management." New York 
RFP, page 46. 
"Screening 
The HMO must conduct periodic EPSDT screens on all 
members under age twenty-one (21) to identify health and 
developmental problems. These screens must be in accordance 
with the periodicity schedule developed by the Department as 
recommended by the American Academy of Pediatrics. These 
screens include: 
Blood lead levels as appropriate and consistent with current 
Centers for Disease Control (CDC) standards. " Pennsylvania 
RFP, page 40. 
"SCREENING 
The Health Plan must conduct periodic EPSDT screens on all 
members under age 2 1 to identify health and developmental 
problems. At a minimum, these screens must include: 
Laboratory tests including lead, TB, newborn screening as 
medically indicated " Rhode Island Contract, page 24. 
"PRENATAL AND I'OSI'NATAL CARE SHALL INCLUDE 
The George Washington University Medical Center 
Center for Health Policy Research 
A) Initial Prenatal Visit ... 
As needed ... - 
Lead screening; ... " Tennessee Contract, Guidelines, pages 
48-54. 
"2 1. Services to CHEC Eqrollees 
HMO shall provide to CHEC participants any service, covered 
under Medicaid, that is necessary to treat or ameliorate a 
defect, physical illness, or a condition identified by a screen 
regardless of whether the service or item is otherwise included 
in a State's Medicaid plan. HMO shall provide preventive 
services and treatment of children under age 21, as prescribed 
in the State Medicaid Provider manual for CHEC services, 
including the periodicity schedule as described in the CHEC 
Provider Manual. All children between six months and 72 
months must be screened for blood lead levels ..." Utah 
Contract, Attachment C, unnumbered pages. 
'b) EPSDT Periodic Screening - Components--A complete 
screening package includes the following components as 
appropriate for the age and sex of the child: ... 
(iv) Lead Toxicity Screening--Blood lead level assessments are 
required in accordance with HHS requirements. Blood lead 
testing may also be done at any time prior to or subsequent to 
the age- appropriate schedule if a history of high-risk or 
elevated blood lead results indicates the need for more frequent 
testing." Virginia Contract, pages 109- 1 12. 
"2.5.2.2 EPSDT (Early and Periodic Screening, Diagnosis and 
Treatment) Services ... 
a. Screening 
The Contractor must provided periodic EPSDT screens for 
members under age 21 ... At a minimum, these screens must 
include the following, 
Laboratory test (including lead) ..." Vermont Contract, page 
32. 
2.6.5 Lead Screening Program 
The health plan must have written policies and procedures to 
provide lead screenings and appropriate retesting in accordance 
with Health Care Financing Administration guidelines. The 
health plan must also provide for appropriate treatment 
services, such as medically-necessary chelation, and agree to 
coordinate delivery of these services with the Department of 
Health." Vermont RFP, pages 2-2 1 - 2-22. 
The George Washington University Medical Center 
Center for Health Policy Research 
Quality Assurance and Performance Measures 
'b. ... Reviewing elements include management of specific 
diagnosis, appropriateness and timeliness of care, 
comprehensiveness of and compliance with the plan of care, 
and evidence of special screening for, and monitoring of, high 
risk individuals or conditions which shall include at least five 
of the following clinical areas of concern: 
(3) Lead toxicity." Florida Contract, page 46. 
"APPENDIX B CLINICAL AND HEALTH SERVICES 
DELIVERY AREAS OF CONCERN 
Clinical Areas of conce m... 
Lead toxicity ..." Kansas Contract, Appendix B, pages 1,2 
. . (  ii) If the child is found to have a blood lead level equal to or 
greater than 10 micrograms per deciliter, providers should use 
their professional judgement, in accordance with the CDC 
guidelines regarding patient management and treatment, as 
well as follow-up blood test and initiation of investigations, to 
determine the source of lead, where indicated ...." 
Massachusetts Contract, Appendix E, Section I, unnumbered 
pages. 
' 1. Services Included ... All services must be provided 
consistent with the scope of services covered by the Michigan 
Medicaid Program on a fee-for-service basis, unless otherwise 
specified by the Department. Health plans must reference all 
applicable Medicaid provider manuals and publications for 
coverages and limitations ... Blood lead follow4ip services for 
individuals under the age of 21 ." Michigan RFP, pages 21-22. 
10.7.1 Plans are responsible for ensuring the following core 
services are available to their members and for reimbursing the 
Department of Health and local health departments as 
specified ... 
(e) Childhood lead poisoning prevention services including 
screening, diagnosis and treatment. Plan providers shall follow 
current CDC guidelines: Preventing Lead Poisoning in Young 
Children. The Director of the Department of Health shall 
provide the plan's medical director with copies of current 
protocols and guidelines upon contract award or at any time 
upon request. 
" 10. Lead poisoning screening for children under the age of six 
(6) and when medically necessary following the recommended 
medical protocols by the Childhood Lead Poisoning Prevention 
Program, Division of Public Health Services: ..." New 
Hampshire RFP, Exhibit A.3, page 3. 
The George Washington University Mcdiuti Center 
Center for Health Policy Research 
'An annual report of the Contractor's monitoring, evaluation, 
and findings regarding the following six (6) priority areas of 
concern identified by HCFA ... 
4. Lead toxicity ..." New Jersey Contract, page 61. 
"Performance Standards for EPSDT Services Service Standard 
Met EPSDT exam-age appropriate 75% Completed 
immunizations for age 75% Lead screening 75%." New Jersey 
Contract, Appendix A, Attachment I, page 137. 
"Screening 
The HMO must conduct periodic EPSDT screens on all 
members under age twenty-one (21) to identify health and 
developmental problems. These screens must be in accordance 
with the periodicity schedule developed by the Department as 
recommended by the American Academy of Pediatrics. These 
screens include: 
Blood lead levels as appropriate and consistent with current 
Center for Disease Control (CDC) standards. " Pennsylvania 
RFP, page 40. 
"TRACKING 
Contractor shall establish a tracking system that provides 
up-to-date information on compliance with EPSDT service 
provision requirements in the following areas: 
Preventive pediatric visits in accordance with the Rhode Island 
EPSDT periodicity schedule and Rhode Island Department of 
Health immunization and lead guidelines ..." Rhode bland 
Contract, pages 26-27. 
"H. CONTINUOUS QUALITY IMPROVEMENT ... 
4) HMO shall submit to TDH a report of the detailed 
information and analysis of the data for the required focused 
studies as directed by TDH - Pregnancy, EPSDT (including 
childhood immunizations and lead), ... collected for the six 
month period ending February 1997, and thereafter in 
consecutive 6 month intervals (referred to herein as "reporting 
period"). The report shall be submitted to TDH within 150 days 
following the close of the reporting pe rid..." Texas Contract, 
Appendix B, unnumbered pages. 
"11. Report Specifications for Preventive Objectives ... 
D. Lead Toxicity Screening 
The objective for calendar year 1997 is 50% ofall Medicaid 
enrollees with their first or second birthday during the reporting 
period (calendar year 1997) who are continuously enrolled for 
the 12 months prior to their first or second birthday will have 
had one blood lead test. Two rates must be reported, one for 
one year olds and one for two year olds ..." Wisconsin 
Contract, pages 15 1 - 155. 
The George Washington University Medical Center 
Center for Health Policy Research 
Data Collection and Reporting 
"ADDENDUM 111 ... 
D.C. MEDICAID MANAGED CARE 
MONTHLY REPORTING FORMAT 
PREPAID HEALTH PLANS 
Report 1 - EPSDT Screening, all members ages 0 through 20 
Note: Detailed EPSDT screening information must be provided 
for every EPSDT procedures performed by patient 
Patient ID# (D.C. Medicaid #) 
Date of Birth 
Date of Service 
EPSDT Code # 
(See Attached Listing) 
Referred for Correction Treatment - Yes/No 
EPSDT REPORTING CODES 
DESCRIPTION LEAD Screening" District of Columbia 
Contract, Addendum 111, pages 1,2,3. 
. .  All laboratory tests for children being screened for lead must 
be sent to the Department of Public Health's state laboratory." 
Illmob Contract, pages 1 1 - 13. 
"Medicaid Managed Care Provider OptionsIMandates for 
coordinating with Department of Health Program and 
Services. .. 
15. Lead Poisoning Prevention and Control 
a) Screening and Treatment 
b) Environmental Assessment ... Plan must repo rt... DOHILHD 
must be reimbursed if they provide ... 
18. DOH Health Laboratory Service ... DOHILHD must be 
reimbursed if they provide ..." Missouri 
RFP, page 100 
'15.7 The contractor's QMP activities will also include, at a 
minimum: ... 
S. An annual report of the contractor's monitoring, evaluation, 
and findings regarding the following 
six (6) priority areas of concern identified by HCFA: ... 
4. Lead toxicity ..." New Jersey Contract, pages 59-61. 
"NOTE: HCFA considers all Medicaid recipients between 6 
months and 6 years of age to be at risk for elevated blood lead 
levels. 
All screening must be done through a blood lead level 
The George Washinglon University Medical Center 
Ccnlcr for Hukh Policy Research 
determination. The EP test is no longer acceptable as a 
screening test for lead poisoning; however, it is still valid as a 
screening test for iron deficiency anemia. 
Results of lead screenings, both positive and negative results, 
must be reported to the local departments of health--the state 
funded County Childhood Lead Poisoning Center. Blood lead 
- 
levels greater than twenty (20) micrograms per decaliter must 
be reported immediately, either via telephone or 
electronically ... 
"2.8.9.5 Lead Poisoning Health plan PCPs will be responsible 
for screening, diagnosing and treating children with elevated 
blood lead levels. PlansIPCPs also must coordinate the care of 
such children with local health departments to assure 
appropriate follow-up by the departments in terms of 
environmental investigation and risk management." New York 
RFP, page 46. 
"The HMO must provide information to the State CLPPP on 
childhood lead poisoning prevention services they provide 





Medical and Environmental Follow-up; 
Referrals for Early Intervention Services; and 
Education and Outreach Activities. 
This information will be necessary for the State CLPPP's 
surveillance system. The Department of Health will provide the 
HMO with STELLAR software for case management." 
Pennsylvania RFP, page 84. 
"TRACKING 
Contractor shall establish a tracking system that provides 
up-to-date information on compliance with EPSDT service 
provision requirements in the following areas: 
Preventive pediatric visits in accordance with the Rhode Island 
EPSDT periodicity schedule and Rhode Island Department of 
Health immunization and lead guidelines ..." Rhode Island 
Contract, pages 26-27. 
"2.08.08 Department Of Health Laboratory 
The Rhode Island Department of Health operates a reference 
laboratory and relies on this laboratory to monitor the incidence 
of lead poisoning and contagious diseases throughout the State. 
To assist in this monitoring process, Contractor agrees to 
submit to the Department of Health laboratory all specimens 
for childhood lead screening, HIV testing, and mycobacteria 
(TB) analysis. Contractor also agrees to submit specimens from 
suspected cases of measles, mumps, rubella, and pertussis 
when required by the State to facilitate investigations of 
outbreaks. Contractor shall negotiate fees directly with the 
The George Washington University Medical Center 
Center for Health Policy Research 
Department of Health laboratory." Rhode Island Contract, 
pages 38-39. 
'H. CONTINUOUS QUALITY IMPROVEMENT ... 
4) HMO shall submit to TDH a report of the detailed 
information and analysis of the data for the required focused 
studies as directed by TDH - Pregnancy, EPSDT (including 
childhood immunizations and lead), ... collected for the six 
month period ending February 1997, and thereafter in 
consecutive 6 month intervals (referred to herein as "reporting 
period"). The report shall be submitted to TDH within 150 days 
following the close of the reporting period ..." Texas Contract, 
Appendix B, unnumbered pages. 
'2.7.8 Department of Health Laboratory and Disease Reporting 
Requirements 
Contractor shall submit all reference specimens for the 
confirmation of positive blood lead .... 
Contractor shall cooperate with the Department of Health and 
its laboratory in all investigations of illness, providing required 
information on cases as well as laboratory results and isolates 
of etiologic agents as appropriate and as spelled out in 
Vermont's communicable disease reporting law. It is the 
responsibility of the Contractor to comply with Vermont 
disease reporting requirements .... The Contractor and/or their 
participating providers (as applicable) who contract with 
out-of-state labs, are responsible for ensuring that the lab 
vendor complies with Vermont's disease reporting 
requirements ... 
In order to protect the public health, any condition which may 
be a public health risk should be reported to the Department of 
Health, Division of Epidemiology." Vermont Contract, page 
40. , . 
"Preventive Care Objectives --...the HMO must measure and 
report activity in the four Preventive Care areas... 
4) Lead Toxicity Preventive Care Objective ..." Wisconsin 
Contract, page. 33. 
"11. Report Specifications for Preventive Care Objectives ... 
"All HMOs that contract with the Wisconsin Department of 
Health and Family Services (DHFS) to provide Medicaid 
services must submit the utilization data requested in the HMO 
Utilization Report. 
A. HMO Utilization Report 
4. Report all services the HMO actually paid for. In, addition, 
the HMO may report services it expects to pay for (i.e., claims 
incurred but not yet paid) through the reporting period ... 
The George Washington University Medical Center 
Center for Health Policy Research 
7. a. Assignment of member months to an age category: When 
calculating member months for each age category, use the 
member's age on the day of each month on which membership 
is tallied ... b. Assignment of age for utilization questions: 
Report age as of date of service for all other utilization 
measures. For inpatient admissions report age as of date of 
discharge ... 
9. Do not count the same procedure twice for the same date of 
service.. . 
12. Treat transfers between institutions as separate admissions 
except where otherwise instructed. Report separate admissions 
when the transferis between acute and non- acute levels of 
services, and mental health1AODA and acute services. 
13. Report inpatient utilization by discharge date rather than 
admission date ... 
16. The HMO Utilization Report data must be reported in the 
computer readable format. The report layout is specified in the 
Utilization Reporting Users Manual." Wisconsin Contract, 
pages 90 - 92. 
. . H .  Number of unduplicated enrollees under age 6 receiving 
blood testing: (submit all recipient history for all enrollees 
included in this category) ..." Wisconsin Contract, pages 98- 
103. 
"Al. Number of unduplicated enrolles under age 2 1 who 
received at least one comprehensive 
Health check screen and total number of screens provided: 
(submit all recipient history data for all enrollees included in 
this category) ... 
Laboratory tests (including appropriate blood-lead screening 
and testing) ... 
A2. Number of unduplicated enrolles who have received a 
Healthcheck screening and were 
referred for diagnosticltreatment services as a result of the 
screen: (excluding vision, dental and 
hearing services) ... " Wisconsin Contract, pages 99-100. 
Relationships with Public Health Agencies 
. . I f  a child is found to have elevated blood lead levels in 
accordance with standards disseminated by DCH, a referral 
should be made to the local health department for follow-up 
services which may include an epidemiological investigation to 
determine the source of blood lead poisoning." Michigan RFP, 
pages 27-28. 
10.7.1 Plans are responsible for ensuring the following core 
services are available to their members and for reimbursing the 
Department of Health and local health departments as 
The George Washington University Medical Ccnlei 
Center for Health Policy Research 
specified ... 
(e) Childhood lead poisoning prevention services including 
screening, diagnosis and treatment. Plan providers shall follow 
current CDC guidelines: Preventing Lead Poisoning in Young 
Children. The Director of the Department of Health shall 
provide the plan's medical director with copies of current 
protocols and guidelines upon contract award or at any time 
upon request. 
10.7.2 Other services offered by the Department of Health and 
local health departments and the method of reimbursement 
include: 
(a) Environmental lead assessments for plan children with 
elevated blood levels will be reimbursed directly by the state - 
Medicaid agency ...." Missouri RFP, pages 34,34A, 34B, 35 
"2.5 Public Health Clinic Access 
Give each ENROLLEE, including adolescents, the opportunity 
go to any public health clinic for immunizations and blood lead 
testing (but not well-child screens) without requiring a referral. 
The CONTRACTOR shall also make a reasonable effort to 
contract with all county public health clinics. At a minimum 
the contractor shall reimburse such public health clinics at the 
MEDICAID rate. The CONTRACTOR may require public 
health clinics to submit claims or reports in specified formats 
before reimbursing services." Montana Contract, pages 1-10. 
"10. Lead poisoning screening for children under the age of six 
(6) and when medically necessary following the recommended 
medical protocols by the Childhood Lead Poisoning Prevention 
Program, Division of Public Health Services: ..." New 
Hampshire RF~,'fexhibit A.3, page 3. 
"2.8.9.5 Lead Poisoning Health plan PCPs will be responsible 
for screening, diagnosing and treating children with elevated 
blood lead levels. PlansIPCPs also must coordinate the care of 
such children with local health departments to assure 
appropriate follow-up by the departments in terms of 
environmental investigation and risk management." New York 
RFP, page 46. 
'The HMO must provide information to the State CLPPP on 
childhood lead poisoning prevention services they provide 





Medical and Environmental Follow-up; 
Referrals for Early Intervention Services; and 
Education and Outreach Activities. 
This information will be necessary for the State CLPPP's 
surveillance system. The Department of Health will provide the 
HMO with STELLAR software for case management.'' 
Pennsylvania UFP, page 84. 
The George Washington University Medical Center 
Center for Health Policy Research 
"2.07 COORDINATION WITH OUT-OF-PLAN SERVICES 
AND OTHER HEALTH/ SOCIAL SERVICES AVAILABLE 
TO MEMBERS ... 
2.07.04.02 Lead Program 
The Department of Health provides a variety of services within 
its Lead Program, including case management, home 
assessments, environmental interventions, and consultation to 
providers. Contractor agrees to have written policies and 
procedures to provide lead screening education, and any 
medically necessary lead reduction therapies and must agree to 
work cooperatively with the Department of Health Lead 
Program to coordinate delivery of these services with those 
provided through the Department of Health." Rhode Island 
Contract, pages 31,33. 
"2.5.2.2 EPSDT (Early and Periodic Screening, Diagnosis and 
Treatment) Services ... 
2.6 Coordination With Out-of-Plan Services 
The Contractor is not obligated to provide or pay for any 
non-capitated services. However, Contractor must establish 
processes to coordinate in-plan service delivery with services 
delivered outside the pl an... Consultation should occur between 
the health plan provider and the out of plan provider where 
clinically appropriate. The areas where coordination between 
health plans and other services is a priority are the described in 
the RFP, including coordination with the following.. Lead 
Screening Progr am..." Vermont Contract, pages 32,35. 
'2.6.5 Lead Screening Program 
The health plan must have written policies andprocedures to 
provide lead screenings and appropriate retesting in accordance 
with Health Care Financing Administration guidelines. The 
health plan must also provide for appropriate treatment 
services, such as medically-necessary chelation, and agree to 
coordinate delivery of these services with the Department of 
Health." Vermont RFP, pages 2-21 - 2-22. 
T h e  following specific services have been delineated with the 
hope of linking Medicaid Managed Care Plans with Local 
Health Departments. Linking primary care and public health is 
an essential strategy to strengthen the health of local 
communities and thus benefit the population of the state as a 
whole .... 
LHDs provide health-related home/community inspections in 
areas that include Lead Poisoning, " Wisconsin Contract, 
pages 160-161. 
The George Washington University Medical Center 
Center for Health Policy Research 
